Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11041223rdf:typepubmed:Citationlld:pubmed
pubmed-article:11041223lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11041223lifeskim:mentionsumls-concept:C0038317lld:lifeskim
pubmed-article:11041223lifeskim:mentionsumls-concept:C0302600lld:lifeskim
pubmed-article:11041223lifeskim:mentionsumls-concept:C0227843lld:lifeskim
pubmed-article:11041223lifeskim:mentionsumls-concept:C0205065lld:lifeskim
pubmed-article:11041223lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:11041223lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:11041223pubmed:dateCreated2001-1-17lld:pubmed
pubmed-article:11041223pubmed:abstractTextA key mechanism underlying the cyclical growth of the endometrium is its ability to regenerate a vascular capillary network. In normal cycling human endometrium, angiogenesis is influenced by both endocrine and paracrine factors. Hormonal manipulation of the endometrium, such as that occurring during the use of steroidal contraception, appears to result in capillary proliferation and fragility. As a consequence of these vascular changes, contraceptive users may be predisposed to unpredictable uterine bleeding, which is responsible for the high frequency of contraceptive discontinuation. In this paper we address mechanisms responsible for vascular endothelial cell proliferation in normal and contraceptive steroid-exposed endometria. We propose that regulation of endometrial angiogenesis is mediated indirectly, via steroid and cytokine actions on vascular endothelial growth factor (VEGF), and we present data indicating that VEGF expression in normal endometrial stromal cells is increased by oestrogens and progestins. Three proinflammatory cytokines with angiogenic effects in other systems (i.e. interleukin-1beta, tumour necrosis factor-alpha and interferon-gamma) do not appear to up-regulate VEGF expression in normal endometrial stromal cells. Well-characterized in-vitro models in conjunction with immunohistochemistry provide useful experimental systems to study endometrial neovascularization under physiological conditions and in those potentially perturbed via the use of contraceptive steroids.lld:pubmed
pubmed-article:11041223pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:languageenglld:pubmed
pubmed-article:11041223pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:citationSubsetIMlld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041223pubmed:statusMEDLINElld:pubmed
pubmed-article:11041223pubmed:monthAuglld:pubmed
pubmed-article:11041223pubmed:issn0268-1161lld:pubmed
pubmed-article:11041223pubmed:authorpubmed-author:TaylorR NRNlld:pubmed
pubmed-article:11041223pubmed:authorpubmed-author:DarneyP DPDlld:pubmed
pubmed-article:11041223pubmed:authorpubmed-author:KornA PAPlld:pubmed
pubmed-article:11041223pubmed:authorpubmed-author:ShifrenJ LJLlld:pubmed
pubmed-article:11041223pubmed:authorpubmed-author:LebovicD IDIlld:pubmed
pubmed-article:11041223pubmed:authorpubmed-author:MuellerM DMDlld:pubmed
pubmed-article:11041223pubmed:authorpubmed-author:RyanI PIPlld:pubmed
pubmed-article:11041223pubmed:issnTypePrintlld:pubmed
pubmed-article:11041223pubmed:volume15 Suppl 3lld:pubmed
pubmed-article:11041223pubmed:ownerNLMlld:pubmed
pubmed-article:11041223pubmed:authorsCompleteYlld:pubmed
pubmed-article:11041223pubmed:pagination67-77lld:pubmed
pubmed-article:11041223pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:meshHeadingpubmed-meshheading:11041223...lld:pubmed
pubmed-article:11041223pubmed:year2000lld:pubmed
pubmed-article:11041223pubmed:articleTitleOvarian steroid and cytokine modulation of human endometrial angiogenesis.lld:pubmed
pubmed-article:11041223pubmed:affiliationDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco 94143-0556, USA.lld:pubmed
pubmed-article:11041223pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11041223pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11041223lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11041223lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11041223lld:pubmed